Showing results (151-160 of 192) with videos related to
Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2021
Deep RNA Sequencing Revealed Fusion Junctional Heterogeneity May Predict Crizotinib Treatment Efficacy in ALK-Rearranged NSCLCZhengbo Song, Shifeng Lian, Silvia Mak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLCLanlan Pang, Yihua Huang, Weitao Zhuang, et al.Translational Lung Cancer Research|September 12, 2024
Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancerJinyu Long, Ying Chen, Xingguang Luo, et al.The Oncologist|June 14, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical TrialZongyang Yu, Xiuyu Cai, Zhengwu Xu, et al.BMC Medicine|February 1, 2022
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trialZhengbo Song, Yuping Li, Shiqing Chen, et al.Translational Lung Cancer Research|January 24, 2022
A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancerZhihua Zhu, Weijian Mei, Zhengbo Song, et al.Cancer Discovery|January 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D InhibitorLing Xie, Chunwei Xu, Han Si, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2020
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLCKai Zhang, Xiaohua Hong, Zhengbo Song, et al.Journal of Thoracic Disease|September 15, 2025
Inclusion of anti-vascular therapy as a promising option for later-line treatment of malignant pleural mesothelioma: a retrospective studyKeda Shao, Di Wu, Qian Wang, et al.The Lancet. Respiratory Medicine|June 13, 2024
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trialZiming Li, Xiaomin Dang, Dingzhi Huang, et al.Pageof 20